Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen-Reference-Cited by-同舟云学术

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

Published:2000-04 Issue:4 Volume:55 Page:481-485
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Recker Franz,Kwiatkowski Maciej K,Piironen Timo,Pettersson Kim,Huber Andreas,Lümmen Gerd,Tscholl Reto

Publisher

Elsevier BV

Subject

Urology

Reference17 articles.

1. Human kallikrein 2 (hK2) and prostate specific antigen (PSA);Rittenhouse;Crit Rev Clin Lab Sci,1998

2. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2;Lovgren;Biochem Biophys Res Commun,1997

3. Correlation of human glandular kallikrein (hK2) with free and total prostatic specific antigen (PSA) and alpha 1 antichymotrypsin in different prostatic diseases;Recker;Akt Urol,1998

4. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL;Kwiatkowski;Urology,1998

5. Improving the specificity of PSA’s in the diagnostic gray zone 4–10 ng/ml by human glandular kallikrein;Recker;Urologe A,1998

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Biofluid Assays for Prostate Cancer;Cancers;2023-12-28

2. Reply to: Spurious results for total and free prostate-specific antigen (PSA); sometimes really “a riddle wrapped in a mystery inside an enigma”;Clinical Chemistry and Laboratory Medicine (CCLM);2022-03-08

3. Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology;Genomics;2019-07

4. “Mix-to-Go” Silver Colloidal Strategy for Prostate Cancer Molecular Profiling and Risk Prediction;Analytical Chemistry;2018-09-27

5. Molecular Biomarkers in the Clinical Management of Prostate Cancer;Cold Spring Harbor Perspectives in Medicine;2018-01-08